AI assistant
Sending…
Xspray Pharma — Major Shareholding Notification 2022
Oct 31, 2022
3129_iss_2022-10-31_bb1a5d8d-54a0-4a06-bb46-6bff9179d325.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer XSpray Pharma AB (publ)
Holder
Flerie Invest AB
Instrument
| Instrument | Aktier SE0009973563 | |
|---|---|---|
| Before the transaction | ||
| Shares | 3,022,378 | |
| Voting rights | 3,022,378 | |
| Transaction | ||
| Reason for major shareholding notification New share issue | ||
| Date | 31/10/2022 | |
| Limit for number of shares | 15 % | |
| Limit for number of votes | 15 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 3,439,378 | |
| Directly held voting rights | 3,439,378 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 15.16453 % | |
| Directly held voting rights | 15.16453 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 15.16453 % | 3,439,378 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 15.16453 % | 3,439,378 |
| Group total holdings |
||
| Voting rights 3,439,378 Percentage of voting rights 15.16453 |
||
| Published | ||
| 31/10/2022 15:41 Contact |
||
| Name Cecilia Schéele |
||
| Phone +46706006856 Email [email protected] |
||
| CLOSE |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Xspray Pharma
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
Jun 5
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Major Shareholding Notification
2026
May 4
Share Issue/Capital Change
2026
Apr 30
Share Issue/Capital Change
2026
Apr 30
Interim / Quarterly Report
2026
Apr 28
Interim / Quarterly Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 9